Decrease of Lewis frequency in HIV-infected patients: Possible competition of fucosylated antigens with HIV for binding to DC-SIGN

AIDS

Volumn 19, Issue 6, 2005, Pages 627-630

  Puissant, Bénédicte ^a,b   Roubinet, Francis ^a,c   Dellacasagrande, Jérôme ^d   Massip, Patrice ^e   Abbal, Michel ^a,b   Pasquier, Christophe ^e   Izopet, Jacques ^e   Blancher, Antoine ^a,b  

^a UNIVERSITÉ PAUL SABATIER   (France)

^b CHU RANGUEIL   (France)

^c Etab Francais Sang Pyrenees M   (France)

^d Societe Cayla   (France)

^e CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOVINE SERUM ALBUMIN; FUCOSYLTRANSFERASE; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; BINDING COMPETITION; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; BLOOD GROUP LEWIS SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; MAJOR CLINICAL STUDY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 17444387761     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000163941.85940.4a     Document Type: Article

References (19)

1. Pollakis G, Kang S, Kliphuis A, Chalaby MI, Goudsmit J, Paxton WA. N-linked glycosylation of the HIV type-1 gp120 enve-lope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J Biol Chem 2001; 276:13433-13441.
2. Ogert RA, Lee MK, Ross W, Buckler-White A, Martin MA, Cho MW. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism. J Virol 2001; 75:5998-6006.
3. Hong PW, Flummerfelt KB, de Parseval A, Gurney K, Elder JH, Lee B. Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding. J Virol 2002; 76:12855-12865.
4. Lin G, Simmons G, Pohlmann S, Baribaud F, Ni H, Leslie GJ, et al. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 2003; 77:1337-1346.
5. Ly A, Stamatatos L. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J Virol 2000; 74:6769-6776.
6. Botarelli P, Houlden BA, Haigwood NL, Servis C, Montagna D, Abrignani S. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes. J Immunol 1991; 147:3128-3132.
7. Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Ruvoen N, Clement M, et al. ABH and Lewis histo-blood group antigens, a model for the meaning of oligosaccharide diversity in the face of a changing world. Biochimie 2001; 83:565-573.
8. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000; 100:587-597.
9. Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003; 170:1635-1639.
10. Frison N, Taylor ME, Soilleux E, Bousser MT, Mayer R, Monsigny M, et al. Oligolysine-based oligosaccharide clusters: selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin. J Biol Chem 2003; 278:23922-23929.
11. Oriol R, Danilovs J, Lemieux R, Terasaki P, Bernoco D. Lymphocytotoxic definition of combined ABH and Lewis antigens and their transfer from sera to lymphocytes. Hum Immunol 1980; 1:195-205.
12. Cartron JP, Mulet C, Bauvois B, Rahuel C, Salmon C. ABH and Lewis glycosyltransferases in human red cells, lymphocytes and platelets. Rev Fr Transfus 1980; 23:271-282.
13. Adachi M, Hayami M, Kashiwagi N, Mizuta T, Ohta Y, Gill MJ, et al. Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC). J Exp Med 1988; 167:323-331.
14. Hansen JE, Clausen H, Nielsen C, Teglbjaerg LS, Hansen LL, Nielsen CM, et al. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J Virol 1990; 64:2833-2840.
15. Greenwell P, Ball MG, Watkins WM. Fucosyltransferase activities in human lymphocytes and granulocytes. Blood group H-gene-specified alpha-2-L- fucosyltransferase is a discriminatory marker of peripheral blood lymphocytes. FEBS Lett 1983; 164:314-317.
16. Viard JP, Burgard M, Hubert JB, Aaron L, Rabian C, Pertuiset N, et al. Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level. AIDS 2004; 18:45-49.
17. Ravn V, Dabelsteen E. Tissue distribution of histo-blood group antigens. Apmis 2000; 108:1-28.
18. Jameson B, Baribaud F, Pohlmann S, Ghavimi D, Mortari F, Doms RW, et al. Expression of DC-SIGN by dendritic cells of intestinal and genital mucosae in humans and rhesus macaques. J Virol 2002; 76:1866-1875.
19. Holgersson J, Clausen H, Hakomori S, Samuelsson BE, Breimer ME. Blood group A glycolipid antigen expression in kidney, ureter, kidney artery, and kidney vein from a blood group A1Le(a-b+) human individual. Evidence for a novel blood group A heptaglycosylceramide based on a type 3 carbohydrate chain. J Biol Chem 1990; 265:20790-20798.